Low Thoracic Muscle Mass: A Novel Indicator of Poor Prognosis in Patients With Severe Fever With Thrombocytopenia Syndrome
Immunity, Inflammation and Disease · 2025-09 · 13 (9)
DOI: 10.1002/iid3.70271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 23.09.2025. Verfasst von Xiao-Min Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People's Republic of China. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the research fund project of Anhui Medical University (2023xkj044)..
Abstract (Originalsprache)
Background
Severe fever with thrombocytopenia syndrome (SFTS) poses a serious threat to public health due to its high mortality. Low thoracic muscle mass predicts poor clinical outcomes in many diseases, but its significance in SFTS remains unclear.
Methods
This retrospective study involved 210 SFTS patients admitted to the First Affiliated Hospital of Anhui Medical University from 2020 to 2023. All subjects underwent chest computed tomography (CT) examination. Skeletal muscle index (SMI) was measured by CT images at the level of the twelfth thoracic vertebra (T12). The clinical data of patients from the survival and non‐survival groups were compared, and the prognostic value of T12‐SMI in SFTS patients was evaluated through least absolute shrinkage and selection operator regression and univariate and multivariate Cox regression.
Results
Patients in the non‐survival group had a lower SMI. Receiver operating characteristic analysis indicated that SMI may predict adverse outcomes in patients with SFTS. Multivariate Cox regression analysis demonstrated that SMI was independently connected to negative outcomes of SFTS. T12‐SMI was correlated with albumin and creatinine.
Conclusion
Low SMI is associated with adverse outcomes in patients with SFTS. SMI may serve as a reliable prognostic marker for SFTS in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People's Republic of China.
- Department of Vascular Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People's Republic of China.
- Department of Orthopedics, Anhui Public Health Clinical Center, Hefei, Anhui Province, People's Republic of China.
ORCID-Profile: Da-Wei Zhang
Förderung
- This study was supported by the research fund project of Anhui Medical University (2023xkj044).
Zitieren
APA
Wang, X. M., Li, P., Hu, L., Zhang, X., Wang, J., Zhu, C. X., Lv, K., & Zhang, D. W. (2025). Low Thoracic Muscle Mass: A Novel Indicator of Poor Prognosis in Patients With Severe Fever With Thrombocytopenia Syndrome. Immunity, Inflammation and Disease, 13(9). https://doi.org/10.1002/iid3.70271
Vancouver
Wang XM, Li P, Hu L, Zhang X, Wang J, Zhu CX, et al. Low Thoracic Muscle Mass: A Novel Indicator of Poor Prognosis in Patients With Severe Fever With Thrombocytopenia Syndrome. Immunity, Inflammation and Disease. 2025;13(9). doi:10.1002/iid3.70271
BibTeX
@article{Wang2025,
author = {Wang, Xiao-Min and Li, Pu and Hu, Lei and Zhang, Xiao and Wang, Jun and Zhu, Cheng-Xin and Lv, Kun and Zhang, Da-Wei},
title = {Low Thoracic Muscle Mass: A Novel Indicator of Poor Prognosis in Patients With Severe Fever With Thrombocytopenia Syndrome},
journal = {Immunity, Inflammation and Disease},
year = {2025},
volume = {13},
number = {9},
doi = {10.1002/iid3.70271}
}
EUVIMED